Studying amphotericin B in patients on ECMO
Part of Infections clinical trials.
This study looks at how a medicine called L-AmB (a type of amphotericin B, used to treat fungal infections) works in patients who are on ECMO. The goal is to find the right dose for people in your situation.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You are currently in the intensive care unit (ICU).
- You are on ECMO, a machine that helps your heart and lungs work.
- You have been diagnosed with a fungal infection (confirmed or highly suspected by a doctor).
- You are not allergic to the study drug (amphotericin B).
- You are not pregnant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at how a specific antifungal medicine, called liposomal amphotericin B, given over a longer period, helps prevent serious fungal infections in people undergoing treatment for cancer or receiving a stem cell transplant. It may be an option if you are at high risk for these infections.
This study looks at how the body processes the antifungal medicine liposomal amphotericin B in people who are also having plasma exchange (a blood-filtering procedure). The goal is to understand if dosing needs to be adjusted when both treatments are used together.
This trial tests a low dose of an antifungal medicine (liposomal amphotericin B) to prevent fungal infections in patients whose white blood cell counts are very low for more than a week. It may help patients who are at high risk for fungal infections and cannot take other antifungal drugs.
This trial tests a low dose of an antifungal medicine (liposomal amphotericin B) to prevent serious fungal infections in children whose immune system is weak after cancer treatment or a stem cell transplant. It's for kids aged 3 to 17 who are at high risk for these infections.
This trial tests whether amphotericin B can treat new fungal infections that develop in people with blood cancers even after they have taken preventive antifungal medicine. It may help patients who have a confirmed or suspected fungal infection while on that prevention.
This study follows children and teens with blood cancers who got a fungal infection while on preventive antifungal medicine. It looks at how well liposomal amphotericin B (AmBisome) works and how safe it is for them.
Hear when a new Invasive Fungal Infections trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.